Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Basepair
Basepair

Basepair

Pre-Seed

Basepair: Simplifying genomics data analysis with our innovative SaaS, revolutionizing medicine and agriculture.

HQ
New York City, NY, US
Founded
2017
Overview
Compare
Fundraising
Employees

Basepair, founded with the mission to simplify genomics data analysis, offers an innovative Software-as-a-Service (SaaS) platform designed to revolutionize medicine, research, and agriculture. The platform enables users to perform Next-Generation Sequencing (NGS) analysis in their own AWS accounts, ensuring enhanced security and cost efficiency by eliminating data movement. Basepair aims to make genomic data analysis as straightforward as booking a flight online, thereby accelerating the adoption of genomics in various fields.

Notable figures affiliated with Basepair include industry leaders in healthcare and life sciences who trust and utilize the platform for their research needs. Key achievements of Basepair include the development of a user-friendly, secure, and cost-effective cloud-based bioinformatics solution that has garnered recognition and trust within the scientific community. The overall impact of Basepair is significant, as it addresses the critical bottleneck of data analysis and interpretation in genomics, facilitating advancements in personalized medicine, agricultural innovation, and scientific research.

Basepair - Similar Companies

Era7 Bioinformatics logo

Era7 Bioinformatics

Streamline Genomics logo

Streamline Genomics

GenomeNext logo

GenomeNext

Sequegenics logo

Sequegenics

sequegenics.com

Nest Genomics logo

Nest Genomics

nestgenomics.com

Sequencing.com logo

Sequencing.com

sequencing.com

BioTuring logo

BioTuring

bioturing.com

HypaHub logo

HypaHub

hypahub.com

Seven Bridges logo

Seven Bridges

sevenbridges.com

Nucleus logo

Nucleus

Benchling logo

Benchling

benchling.com

Bioinfoexperts logo

Bioinfoexperts

bioinfox.com

Karyosoft logo

Karyosoft

karyosoft.com

Rosalind logo

Rosalind

rosalind.bio

Insightful Science logo

Insightful Science

Basepair - Quick Facts

Who are Basepair's competitors?

Companies similar to Basepair include Era7 Bioinformatics, Streamline Genomics, GenomeNext and Sequegenics.

When was Basepair founded?

Basepair was founded in 2017.

Where is Basepair's headquarters located?

Basepair's headquarters is located in New York City, NY, US.

When was Basepair's last funding round?

Basepair's most recent funding round was for $1.1M (USD) in September 2021.

How much has Basepair raised to-date?

As of Sep 28, 2021, Basepair has raised a total of $2.8M (USD).

How many employees does Basepair have?

Basepair has 11 employees as of Feb 5, 2024.

Basepair - Classification

Ownership
  • Venture Capital
Technology
  • AI
Geographic Exposure
  • Global
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Genomics Analysis
Tags
  • Cloud
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software